SEC asks for more data to grant full market approval to...
New Delhi [India], January 14 (ANI): The Drugs Controller General of India's (DCGI) Subject Expert Committee...
DCGI's SEC to review applications of Bharat Biotech, SII for...
New Delhi [India], January 14 (ANI): Drugs Controller General of India (DCGI)'s Subject Expert Committee will...
COVID-19 vaccine Covaxin now universal vaccine for adults,...
New Delhi [India], January 14 (ANI): Hyderabad-based vaccine manufacturer Bharat Biotech on Thursday announced...
Covaxin can neutralise Delta, Omicron variants of...
New Delhi [India], January 12 (ANI): Hyderabad-based Bharat Biotech on Wednesday claimed that its COVID vaccine...
COVAXIN booster dose trial demonstrates long-term safety with...
COVID-19: Bharat Biotech urges healthcare workers to ensure...
Hyderabad (Telangana) [India], January 8 (ANI): Hyderabad-based vaccine manufacturer Bharat Biotech on Friday...
No paracetamol or pain killers are recommended after being...
Bharat Biotech gets SEC approval for phase 3 clinical trials...
New Delhi [India], January 5 (ANI): The Subject Experts Committee (SEC) of the Drug Controller General of India...
SEC to hold meeting on Bharat Biotech's Nasal vaccine booster dose
COVID-19: India supplies 5 lakh more Covaxin doses to Afghanistan
Covaxin found to be safe, immunogenic in 2-18 age group in...
Proven record for safety, says Bharat Biotech after Covaxin...
Copyright © aninews.in | All Rights Reserved.